GN Store Nord A/S (GNNDY) Fair Value & Analysis
Healthcare · US · Market cap $2.0B
GN Store Nord A/S
GNNDY · US
Fair value as of: Jul 16, 2026
From 26 valuation models · updated 9 days ago
Fair value updated Jul 16, 2026, revised from $33.73 to $34.11 (+1.1%) since Jun 24, 2026. Share price +1.7% over the past month.
Price vs Fair Value (12 months)
12‑month range $39.78 – $57.22 · fair‑value band $24.57 – $56.75 · the $41.75 price screens above the $34.11 fair value. As of Jul 16, 2026.
✦ Which stocks are undervalued right now? Check free Discover now →Analysis
GN Store Nord A/S (GNNDY) currently trades at $41.75, while our model-based Fair Value estimate is $34.11, implying the stock looks roughly 18.3% overvalued today. We read business quality at 34/100 (below-average quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium, the entry price still matters most (evidence: high).
Over the trailing twelve months, GN Store Nord A/S generated revenue of $16.6B at a net margin of -2.3%. Revenue declined 8.2% year over year. It earns a return on equity of 3.0%. Net debt stands at $9.7B. Fundamentals as of Jul 16, 2026
Our scenario range runs from $24.57 (bear case) to $56.75 (bull case); at $41.75, the current price sits within that range. The share trades about 27% below its 52-week high and 5% above its 52-week low, currently below its 200-day average. For context, the median of 10 Healthcare peers we cover trades at -26% fair-value upside, at -18%, GNNDY screens cheaper than that median.
Key figures & financial health
More key figures
Figures from reported company fundamentals (EODHD) · as of Jul 16, 2026. TTM = trailing twelve months.
About the company
GN Store Nord A/S provides hearing, audio, video, and gaming solutions in Denmark, Europe, North America, and internationally. The company operates through Hearing, Enterprise, and Gaming segments. The Hearing segment produces and sells hearing instruments and products. The Enterprise segment supplies audio and video devices for professional use. The Gaming segment produces gaming devices and peripherals. It offers its products under the ReSound, Beltone, Interton, Danavox, Jabra Enhance, Jabra, BlueParrott, FalCom, SteelSeries, and KontrolFreek brands. GN Store Nord A/S was founded in 1869 and is based in Ballerup, Denmark.
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
GN Store Nord A/S reported revenue of $16.8B in FY2025 versus $15.8B in FY2021, a compound +1.6%/yr. Reported net income was $653M in FY2025, compounding −21.9%/yr from FY2021.
Is GNNDY fairly valued? → Check now
Similar stocks
10 more Medical Devices stocks, each showing price versus our Fair Value estimate (as of Jul 16, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| Abbott Laboratories, ABT | $89.17 | $70.59 | -21% |
| Stryker Corporation SYK | $308.84 | $187.83 | -39% |
| Medtronic plc MDTC34 | R$211.05 | R$29.52 | -86% |
| Boston Scientific Corporation B1SX34 | R$229.31 | R$34.74 | -85% |
| Edwards Lifesciences Corporation EWL | €74.82 | €32.56 | -56% |
| Siemens Healthineers AG SEMHF | $39.95 | $44.36 | +11% |
| Shenzhen Mindray Bio-Medical Electronics Co 300760 | ¥149.43 | ¥147.63 | -1% |
| STERIS plc S1TE34 | R$52.14 | R$39.50 | -24% |
| Zimmer Biomet Holdings Z1BH34 | R$116.16 | R$85.57 | -26% |
| Shanghai United Imaging Healthcare Co 688271 | ¥104.19 | ¥45.36 | -56% |
Explore undervalued stocks
More undervalued Healthcare stocks →
Frequently asked questions
Is GN Store Nord A/S (GNNDY) undervalued?
What is the fair value of GNNDY?
What is the quality score of GNNDY?
What is the revenue of GN Store Nord A/S (GNNDY)?
What is the net profit margin of GNNDY?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.
Unlock the full GN Store Nord A/S analysis, and try Pro free
One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.
Zero risk: nothing is ever charged. After 14 days you decide whether to stay.
Not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.